How have SHTDF shares performed in 2024?

Sinopharm Group's stock was trading at $2.49 on January 1st, 2024. Since then, SHTDF shares have increased by 2.0% and is now trading at $2.54. View the best growth stocks for 2024 here .

Is Sinopharm Group a good dividend stock?

Sinopharm Group (OTCMKTS:SHTDF) pays an annual dividend of $0.26 per share and currently has a dividend yield of 1.11%. The dividend payout ratio is 26.05%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Sinopharm Group?

Shares of SHTDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:SHTDF

Sinopharm Group (SHTDF) Stock Price, News & Analysis

→ With the “Bitcoin Loophole” you can supercharge the gains by 10x or more (From DTI) (Ad)

Free SHTDF Stock Alerts

$2.54

0.00 (0.00%)

(As of 04/17/2024 ET)

Compare

Today's Range: $2.54
▼
$2.54
50-Day Range: $2.46
▼
$2.95
52-Week Range: $2.30
▼
$3.63

Volume: N/A
Average Volume: 736 shs
Market Capitalization: N/A

P/E Ratio: 2.54
Dividend Yield: 10.24%
Price Target: N/A

Stock Analysis Chart Financials Short Interest

Get Sinopharm Group alerts:

Ad Paradigm Press

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Sinopharm Group Stock (OTCMKTS:SHTDF)

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.

SHTDF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SHTDF Stock News Headlines

April 10, 2024 | americanbankingnews.com

Sinopharm Group (OTCMKTS:SHTDF) Stock Passes Below Two Hundred Day Moving Average of $2.63

April 6, 2024 | morningstar.com

Sinopharm Group Co Ltd ADR X2S1

April 18, 2024 | DTI (Ad)

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…

February 21, 2024 | morningstar.com

Sinopharm Group Co Ltd 01099

January 30, 2024 | morningstar.com

Sinopharm Group Co Ltd X2S

November 8, 2023 | morningstar.com

Sinopharm Group Co Ltd SHTDF

May 12, 2023 | msn.com

Sinopharm Group (HKEX:1099) Price Target Increased by 8.31% to 29.48

April 13, 2023 | finance.yahoo.com

Pfizer signs strategic cooperation pact with China's Sinopharm

April 18, 2024 | Priority Gold (Ad)

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

April 6, 2023 | msn.com

WHO chief expects COVID emergency to end this year

March 24, 2023 | msn.com

China approves its first mRNA Covid-19 vaccine

March 22, 2023 | news.yahoo.com

China approves first home-grown mRNA Covid vaccine

February 23, 2023 | forbes.com

Sinopharm Group

January 20, 2023 | news.yahoo.com

Sinopharm unit gets OK for clinical trials of mRNA COVID vaccine

January 20, 2023 | msn.com

Pharma major Sinopharm gets approval for clinical trials of mRNA Covid-19 vaccine

December 8, 2022 | reuters.com

Sinopharm's second Chinese herb shot is potent

December 2, 2022 | seekingalpha.com

Vaxxinity says COVID vaccine outperformed Astra and Sinopharm shots as booster

September 28, 2022 | seekingalpha.com

Merck in pact with Sinopharm to launch oral COVID-19 therapy in China

September 15, 2022 | msn.com

Sinopharm to boost local COVID vaccine production in Africa

September 7, 2022 | msn.com

China’s Sinovac to test Omicron-targeting vaccines in Chile

July 27, 2022 | msn.com

Daesang to set up joint venture with China Sinopharm International

July 17, 2022 | seekingalpha.com

Week In Review: Qiming Closes $3.2 Billion For China Healthcare And Technology Investments

July 4, 2022 | msn.com

Hong Kong could have 3 Omicron-targeting jabs by end of year, as health expert reveals Sinopharm hopes to make new vaccine available by December

June 27, 2022 | msn.com

China Donates 10 Mil Doses of Sinopharm COVID-19 Vaccines, Syringes

June 22, 2022 | usnews.com

Some Omicron Sub-Variants Escaping Antibodies From Sinopharm Shot -Chinese Study

June 21, 2022 | reuters.com

Some Omicron sub-variants escaping antibodies from Sinopharm shot - Chinese study

May 31, 2022 | msn.com

University of Hong Kong, Sinopharm launch city’s first trial for Omicron-targeting vaccine which could be ready in November

See More Headlines

Receive SHTDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sinopharm Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical Distribution
Sub-Industry: N/A
Current Symbol: OTCMKTS:SHTDF
CUSIP: N/A
CIK: 1556605
Web: ir.sinopharmgroup.com.cn
Phone: 86-21-2305-2666
Fax: N/A
Employees: 115,959
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 2.54
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Qingming Yu (Age 60)
Executive Chairman of the Board
Comp: $897.44k
Mr. Yong Liu (Age 55)
President & Executive Director
Comp: $867.85k
Ms. Xiaojuan Li (Age 48)
Chief Financial Officer
Mr. Yijian Wu (Age 54)
Secretary to the Board, Company Secretary & Authorised Representative

Key Competitors

View All Competitors

SHTDF Stock Analysis - Frequently Asked Questions

How have SHTDF shares performed in 2024?: Sinopharm Group's stock was trading at $2.49 on January 1st, 2024. Since then, SHTDF shares have increased by 2.0% and is now trading at $2.54.
View the best growth stocks for 2024 here.
Is Sinopharm Group a good dividend stock?: Sinopharm Group (OTCMKTS:SHTDF) pays an annual dividend of $0.26 per share and currently has a dividend yield of 1.11%. The dividend payout ratio is 26.05%. This payout ratio is at a healthy, sustainable level, below 75%.
How do I buy shares of Sinopharm Group?: Shares of SHTDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SHTDF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial